(Oslo , 2end ofApril 2024 )Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarters inNorway , that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces the Annual General Meeting for the company. The Annual General Meeting will take place on the 24th ofApril 2024 at 10.00 and is held atMedistim's offices at Økernveien 94 inOslo . Attached are the agenda for the meeting, the voting form and the annual report for 2023. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms. Attached is also the annual report for 2023 forMedistim ASA in PDF format and in ESEF format. The report will also be available on the company web site: www.medistim.com. AboutMedistim :Medistim was established in 1984, and has a track record of profitable growth over the past >15 years. The company is a pioneer within its segment, and continues to invest in new product development.Medistim has wholly owned subsidiaries with sales organizations in theUSA ,Canada ,China ,Germany ,UK ,Spain ,Denmark ,Sweden andNorway , in addition to the about 60 distributors inEurope ,Asia ,Middle East ,Africa ,Canada andSouth America . For more information, visit theMedistim home page: www.Medistim.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act (Verdipapirhandelloven). For more information, contact: President and CEO,Kari E. Krogstad ,Medistim ASA Tel: + 47 918 38 110 Email: kari.krogstad@medistim.com CFO,Thomas Jakobsen ,Medistim ASA Tel: + 47 906 59 940 Email: thomas.jakobsen@medistim.com
Click here for more information
© Oslo Bors ASA, source